Abstract
Management of functional intrathoracic sympathetic paragangliomas in succinate dehydrogenase subunit D (SDHD) mutation carriers is challenging, and there is no uniform guideline for treatment to date. The risks of potential malignant behavior and long-term cardiovascular morbidity have to be weighed against the risks of treatment complications. We report the multidisciplinary and shared decision-making approach that resulted in successful surgical removal of 3 paragangliomas in a SDHD mutation carrier.
Original language | English |
---|---|
Pages (from-to) | e87-e90 |
Journal | The Annals of Thoracic Surgery |
Volume | 109 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2020 |